BTIG lowered the firm’s price target on Tactile Systems to $17 from $19 and keeps a Buy rating on the shares post the Q4 report. While investors will be encouraged by a return to growth in Airway Clearance in fiscal 2024 and sustained double-digit adjusted EBITDA margins, Tactile Systems faces a tough set up in fiscal 2024 with a back-half loaded outlook, the analyst tells investors in a research note. However, the firm says the shares reflect this reality with a low valuation.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See Insiders’ Hot Stocks on TipRanks >>
Read More on TCMD:
- Tactile Systems sees FY24 revenue $300M-$305M, consensus $309.2M
- Tactile Systems reports Q4 EPS 35c, consensus 22c
- Tactile Systems Technology, Inc. Reports Fourth Quarter and Full Year 2023 Financial Results; Introduces Full Year 2024 Outlook
- Tactile Medical to Participate in Upcoming Investor Conferences in February and March
- Tactile Medical to Release Fourth Quarter and Fiscal Year 2023 Financial Results on February 20, 2024
